QuidelOrtho
QDEL
13.42
+1.01
+8.14%
QuidelOrtho
US · QDEL
#3374 by market cap
13.42
+1.01
+8.14%
Live - 5344 symbols - heartbeat 142s ago
· 2026-10-09 19:30
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.51, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.89% YoY
Margins
- Gross margin
- 46.67%
- Operating margin
- 2.01%
- Net margin
- -41.45%
Key ratios & quality
- Enterprise valuei
- 3.43B
- Altman Z-Scorei
- 0.51
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 522.29M | 534.89M | 1.66B | 1.70B | 3.27B | 3.00B | 2.78B | 2.73B |
| Gross profit | 315.71M | 320.81M | 1.35B | 1.28B | 1.94B | 1.50B | 1.29B | 1.27B |
| Selling & admin expenses | 153.94M | 163.87M | 200.54M | 239.60M | 621.00M | 763.20M | 766.80M | 746.30M |
| Research & development | 51.65M | 52.55M | 84.29M | 95.70M | 187.90M | 245.00M | 218.70M | 186.20M |
| Operating profit | 110.13M | 104.38M | 1.06B | 915.60M | 982.50M | 257.00M | 45.80M | 54.80M |
| Pretax profit | 63.38M | 77.18M | 1.04B | 900.30M | 735.90M | -29.10M | -2.13B | -1.11B |
| Tax | -10.80M | 4.26M | 230.03M | 196.10M | 187.20M | -19.00M | -79.50M | 24.10M |
| Net profit | 74.18M | 72.92M | 810.29M | 704.20M | 548.70M | -10.10M | -2.05B | -1.13B |
| Basic EPS | 2 | 2 | 19 | 17 | 10 | 0 | -31 | -17 |
| Diluted EPS | 1.86 | 1.73 | 18.60 | 16.43 | 9.56 | -0.15 | -30.54 | -16.69 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 692.80M | 613.90M | 699.90M | 723.60M | 619.80M | 630.90M |
| Gross profit | 343.30M | 274.90M | 335.60M | 320.40M | 263.80M | 272.90M |
| Selling & admin expenses | 187.00M | 178.00M | 186.90M | 194.40M | 199.30M | 189.70M |
| Research & development | 53.20M | 45.70M | 41.50M | 45.80M | 44.90M | 48.70M |
| Operating profit | 48.70M | -1.80M | 45.20M | -37.30M | -27.40M | -15.30M |
| Pretax profit | -8.80M | -229.60M | -756.90M | -112.40M | -79.50M | -81.20M |
| Tax | 3.90M | 25.80M | -23.90M | 18.30M | 12.30M | 11.70M |
| Net profit | -12.70M | -255.40M | -733.00M | -130.70M | -91.80M | -92.90M |
| Basic EPS | 0 | -4 | -11 | -2 | -1 | -1 |
| Diluted EPS | -0.19 | -3.77 | -10.78 | -1.92 | -1.35 | -1.36 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 193.40M | 222.23M | 1.14B | 1.44B | 1.58B | 1.31B | 1.22B | 1.45B |
| Cash & ST investments | 43.70M | 52.78M | 489.94M | 828.50M | 345.00M | 167.30M | 98.30M | 169.80M |
| Inventory | 67.38M | 58.09M | 113.80M | 198.80M | 524.10M | 577.80M | 533.70M | 577.60M |
| Total assets | 806.37M | 910.87M | 1.87B | 2.43B | 8.86B | 8.56B | 6.42B | 5.77B |
| Total current liabilities | 159.74M | 125.89M | 336.96M | 323.50M | 1.01B | 833.80M | 998.80M | 966.10M |
| Short-term debt | 54.38M | 19.07M | 7.80M | 10.30M | 231.90M | 166.50M | 372.90M | 207.60M |
| Long-term debt | 53.19M | -- | -- | 400.00K | 2.43B | 2.27B | 2.14B | 2.47B |
| Total liabilities | 380,787,000.00 | 351,047,000.00 | 538,461,000.00 | 501,000,000.00 | 3,921,200,000.00 | 3,557,200,000.00 | 3,439,100,000.00 | 3,848,800,000.00 |
| Total equity | 425.58M | 559.82M | 1.33B | 1.93B | 4.93B | 5.01B | 2.98B | 1.92B |
| Retained earnings | 61.76M | 134.68M | 944.97M | 1.65B | 2.20B | 2.19B | 135.80M | -996.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.26B | 1.28B | 1.37B | 1.45B | 1.38B | 1.38B |
| Cash & ST investments | 127.10M | 151.70M | 98.10M | 169.80M | 140.40M | 123.40M |
| Inventory | 563.20M | 578.70M | 613.80M | 577.60M | 611.50M | 618.90M |
| Total assets | 6.46B | 6.38B | 5.68B | 5.77B | 5.63B | 5.72B |
| Total current liabilities | 1.05B | 1.14B | 767.90M | 966.10M | 962.40M | 993.40M |
| Short-term debt | 425.00M | 564.20M | 191.80M | 207.60M | 259.50M | 387.50M |
| Long-term debt | 2.11B | 2.07B | 2.50B | 2.47B | 2.46B | 2.54B |
| Total liabilities | 3,464,400,000.00 | 3,586,400,000.00 | 3,638,700,000.00 | 3,848,800,000.00 | 3,777,300,000.00 | 3,940,400,000.00 |
| Total equity | 3.00B | 2.79B | 2.04B | 1.92B | 1.85B | 1.77B |
| Retained earnings | 123.10M | -132.30M | -865.30M | -996.00M | -1.09B | -1.18B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 136.35M | 134.49M | 629.76M | 805.90M | 885.30M | 280.20M | 83.00M | 105.20M |
| Depreciation & amortization | 46.27M | 47.83M | 49.09M | 52.70M | 283.60M | 457.20M | 453.40M | 442.00M |
| Free cash flow | 104.66M | 107.26M | 564.84M | 513.10M | 744.40M | 70.90M | -112.10M | -83.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 12.70M | 14.78M | -34.08M | -95.90M | -47.90M | 4.40M | 5.00M | 6.10M |
| Ending cash balance | 43.70M | 52.78M | 489.94M | 802.80M | 293.90M | 119.50M | 98.50M | 169.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 65.60M | -46.80M | -45.50M | 131.90M | -33.00M | -110.60M |
| Depreciation & amortization | 107.10M | 110.30M | 112.10M | 112.50M | 112.90M | 116.70M |
| Free cash flow | 9.40M | -84.30M | -94.70M | 86.60M | -67.00M | -136.10M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 3.00M | 100.00K | 2.90M | 100.00K | 1.80M | 400.00K |
| Ending cash balance | 127.20M | 151.70M | 98.10M | 169.80M | 140.40M | 123.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 22.73 | 14.80 | 85.63 | 43.18 | 15.99 | -0.20 | -51.36 | -46.15 |
| ROA %i | 8.52 | 8.49 | 58.25 | 32.74 | 9.72 | -0.12 | -27.38 | -18.56 |
| ROIC %i | 15.88 | 14.42 | 77.39 | 40.39 | 12.25 | 1.65 | -28.20 | -18.98 |
| 5-year avg ROE %i | 1.34 | 4.90 | 22.55 | 32.50 | 36.46 | 31.88 | 18.65 | -7.71 |
| EBIT margin %i | 16.79 | 17.19 | 63.19 | 53.34 | 24.81 | 5.00 | -69.83 | -33.87 |
| FCF / sales %i | 20.04 | 20.05 | 33.99 | 30.21 | 22.79 | 2.37 | -- | -- |
| Current ratioi | 1.21 | 1.77 | 3.39 | 4.45 | 1.56 | 1.57 | 1.22 | 1.50 |
| Quick ratioi | 0.75 | 1.23 | 3.02 | 3.78 | 0.92 | 0.79 | 0.55 | 0.77 |
| Debt / assetsi | 13.34 | 12.33 | 5.80 | 5.73 | 32.17 | 30.53 | 41.74 | 49.12 |
| LT debt / equityi | 12.50 | 16.65 | 7.56 | 6.69 | 53.04 | 48.89 | 77.35 | 136.75 |
| Interest coveragei | 3.61 | 6.22 | 109.11 | 158.79 | 10.88 | 0.84 | -10.32 | -5.05 |
| Revenue CAGR (3Y) %i | 38.61 | 40.81 | 81.54 | 48.16 | 82.78 | 21.74 | 17.89 | -5.80 |
| Net income CAGR (3Y) %i | -- | -- | -- | 111.74 | 95.96 | -- | -- | -- |
| FCF CAGR (3Y) %i | 74.05 | -- | 281.17 | 69.88 | 90.75 | -49.93 | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -11.38 | -15.63 | -45.16 | -46.15 | -49.95 | -45.91 |
| ROA %i | -5.45 | -7.14 | -18.91 | -18.56 | -20.03 | -17.34 |
| ROIC %i | -3.70 | -5.66 | -19.24 | -18.98 | -21.10 | -17.86 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -5.68 | -8.34 | -35.31 | -33.87 | -37.24 | -31.16 |
| FCF / sales %i | -- | 0.47 | -- | -- | -- | -- |
| Current ratioi | 1.20 | 1.12 | 1.78 | 1.50 | 1.43 | 1.39 |
| Quick ratioi | 0.54 | 0.48 | 0.80 | 0.77 | 0.65 | 0.60 |
| Debt / assetsi | 41.70 | 43.78 | 50.11 | 49.12 | 51.07 | 53.81 |
| LT debt / equityi | 75.71 | 79.80 | 130.23 | 136.75 | 141.26 | 151.44 |
| Interest coveragei | -0.85 | -1.27 | -5.39 | -5.05 | -5.24 | -4.23 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-09 19:30:06 · For reference only, not investment advice and not tailored to your situation.
QuidelOrtho discussion 0 comments